Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The synergistic tumor growth-inhibitory effect of probiotic Lactobacillus on transgenic mouse model of pancreatic cancer treated with gemcitabine
Shan-Ming Chen, Wee-Wei Chieng, Szu‐Wei Huang, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Gut microbiota–derived short‐chain fatty acids regulate group 3 innate lymphoid cells in HCC
Chupeng Hu, Bingqing Xu, Xiaodong Wang, et al.
Hepatology (2022) Vol. 77, Iss. 1, pp. 48-64
Open Access | Times Cited: 104
Unveiling the role of functional foods with emphasis on prebiotics and probiotics in human health: A review
Oluwatobi Victoria Obayomi, Abiola Folakemi Olaniran, Stephen Olugbemiga Owa
Journal of Functional Foods (2024) Vol. 119, pp. 106337-106337
Open Access | Times Cited: 35
Microbiome as a biomarker and therapeutic target in pancreatic cancer
Ghazaleh Pourali, Danial Kazemi, Amir Shayan Chadeganipour, et al.
BMC Microbiology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 22
Bacteria and bacterial derivatives as delivery carriers for immunotherapy
Sae‐Ryung Kang, Dinh-Huy Nguyen, Su Woong Yoo, et al.
Advanced Drug Delivery Reviews (2021) Vol. 181, pp. 114085-114085
Open Access | Times Cited: 65
The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy
Aneta Sevcikova, Nikola Izoldova, Viola Stevurkova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 488-488
Open Access | Times Cited: 63
Statin prevents cancer development in chronic inflammation by blocking interleukin 33 expression
Jong Ho Park, Mahsa Mortaja, Heehwa G. Son, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Influence of Gut Microbiota-Mediated Immune Regulation on Response to Chemotherapy
Yufei Deng, Xiaoying Hou, Haiping Wang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 604-604
Open Access | Times Cited: 9
Synergistic Interactions Between Probiotics and Anticancer Drugs: Mechanisms, Benefits, and Challenges
Babak Pezeshki, Hussein T. Abdulabbas, Asma M. Alturki, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access | Times Cited: 1
Dysbiosis and extraintestinal cancers
Rui He, Ping-Qian Qi, Lin-Zhen Shu, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
The Role of the Gut Microbiota in Modulating Signaling Pathways and Oxidative Stress in Glioma Therapies
Aleksandra Krawczyk, Gabriela Elzbieta Sladowska, Barbara Strzałka‐Mrozik
Cancers (2025) Vol. 17, Iss. 5, pp. 719-719
Open Access | Times Cited: 1
Immunosuppressive activity is attenuated by Astragalus polysaccharides through remodeling the gut microenvironment in melanoma mice
Guiqing Ding, Qianyi Gong, Jinyun Ma, et al.
Cancer Science (2021) Vol. 112, Iss. 10, pp. 4050-4063
Open Access | Times Cited: 52
Pancreatic cancer cachexia: three dimensions of a complex syndrome
Maximilian Kordes, Lars Larsson, Lars Engstrand, et al.
British Journal of Cancer (2021) Vol. 124, Iss. 10, pp. 1623-1636
Open Access | Times Cited: 49
A comprehensive review of the multifaceted role of the microbiota in human pancreatic carcinoma
Gouri Pandya, Anuradha Kirtonia, Aishwarya Singh, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 682-692
Closed Access | Times Cited: 46
Microbiota in Pancreatic Diseases: A Review of the Literature
Tommaso Schepis, Sara Sofia De Lucia, Enrico Celestino Nista, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 24, pp. 5920-5920
Open Access | Times Cited: 41
The Probiotic Lactobacillus paracasei Ameliorates Diarrhea Cause by Escherichia coli O8via Gut Microbiota Modulation1
Shunan Ren, Chunjie Wang, Aorigele Chen, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 34
The role of the gut microbiota and probiotics associated with microbial metabolisms in cancer prevention and therapy
Zijun Wang, Lanqing Li, Shunshun Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 34
Association of the Microbiota and Pancreatic Cancer: Opportunities and Limitations
Zhou Chen, Shaofeng Zhang, Shi Dong, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Emerging clinical relevance of microbiome in cancer: promising biomarkers and therapeutic targets
Jia‐Hao Dai, Xi-Rong Tan, Han Qiao, et al.
Protein & Cell (2023) Vol. 15, Iss. 4, pp. 239-260
Open Access | Times Cited: 22
Lactobacillus casei combined with Lactobacillus reuteri alleviate pancreatic cancer by inhibiting TLR4 to promote macrophage M1 polarization and regulate gut microbial homeostasis
Zemin Zhu, Bo Yi, Z Tang, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 17
Synergistic immunomodulatory effect of synbiotics pre- and postoperative resection of pancreatic ductal adenocarcinoma: a randomized controlled study
Sara Maher, Hesham A. Elmeligy, Tarek Aboushousha, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 6
Open Access | Times Cited: 7
A Lactobacillus Combination Ameliorates Lung Inflammation in an Elastase/LPS—induced Mouse Model of Chronic Obstructive Pulmonary Disease
Huan‐Ting Shen, Yi‐Ting Fang, Wan-Hua Tsai, et al.
Probiotics and Antimicrobial Proteins (2024)
Open Access | Times Cited: 7
Harnessing the power of probiotic strains in functional foods: nutritive, therapeutic, and next-generation challenges
M.D. Arshad Anwer, Ming Wei
Food Science and Biotechnology (2024) Vol. 33, Iss. 9, pp. 2081-2095
Open Access | Times Cited: 7
Pancreatic Cancer: A Review of Risk Factors
Raluca Roxana Grigorescu, Ioana Alexandra Husar-Sburlan, Cristian Gheorghe
Life (2024) Vol. 14, Iss. 8, pp. 980-980
Open Access | Times Cited: 6
The Role of Gut Microbiota in Modulating Cancer Therapy Efficacy
Mostafa A. Madkour, Rawan A. Altaf, Zeinab S. Sayed, et al.
Advanced Gut & Microbiome Research (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 6
Gut Dysbiosis in Pancreatic Diseases: A Causative Factor and a Novel Therapeutic Target
Tao Zhang, Guangqi Gao, Hafiz Arbab Sakandar, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top